These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7021004)

  • 1. Enzyme measurements by mass: an interim review of the clinical efficacy of some mass measurements of prostatic acid phosphatase and isoenzymes of creatine kinase.
    Henderson AR; Nealon DA
    Clin Chim Acta; 1981; 115(1):9-32. PubMed ID: 7021004
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostatic cancer, acid phosphatase, creatine kinase-BB and race: a prospective study.
    Fair WR; Heston WD; Kadmon D; Crane DB; Catalona WJ; Ladenson JH; McDonald JM; Noll BW; Harvey G
    J Urol; 1982 Oct; 128(4):735-8. PubMed ID: 6183457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunoassay for prostatic acid phosphatase in early prostatic carcinoma.
    Samuell CT; Morgans BT; O'Donoghue EP
    Br J Urol; 1984 Apr; 56(2):208-12. PubMed ID: 6498440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic significance of serum creatine kinase-BB isoenzyme in adenocarcinoma of prostate.
    Aleyassine H; MacIsaac SG
    Clin Biochem; 1980 Jun; 13(3):109-12. PubMed ID: 7418193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of prostatic acid phosphatase in the investigation and treatment of adenocarcinoma of the prostate.
    Bruce AW; Mahan DE
    Ann N Y Acad Sci; 1982; 390():110-21. PubMed ID: 6953923
    [No Abstract]   [Full Text] [Related]  

  • 6. Radioimmunoassay of prostatic acid phosphatase: validation and clinical application.
    Franchimont P; Bouffioux C; Reuter A; Rigo-Betz C; Vrindts-Gevaert Y; Jaspar JM; Lecomte-Yerna MJ
    Int J Cancer; 1983 Feb; 31(2):149-55. PubMed ID: 6826245
    [No Abstract]   [Full Text] [Related]  

  • 7. Early detection of prostatic cancer by radioimmunoassay for prostatic acid phosphatase.
    Med Lett Drugs Ther; 1979 Nov; 21(22):90-1. PubMed ID: 492069
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunoreactive prostate-specific acid phosphatase in prostatic cancer.
    Kontturi M; Vihko P; Lukkarinen O; Vihko R
    Scand J Clin Lab Invest Suppl; 1985; 179():67-74. PubMed ID: 3866311
    [No Abstract]   [Full Text] [Related]  

  • 9. Radioimmunoassay of serum prostatic acid phosphatase in prostatic cancer.
    Br Med J; 1978 Sep; 2(6139):719-20. PubMed ID: 698693
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation of lactic dehydrogenase isoenzymes in prostatic tissue with serum acid phosphatase, digital examination and histological diagnosis.
    Clark SS; Srinivasan V
    J Urol; 1973 Mar; 109(3):444-5. PubMed ID: 4120831
    [No Abstract]   [Full Text] [Related]  

  • 11. Creatine kinase isoenzyme (CK-BB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer.
    Huber PR; Zaugg T; Linder E; Hagmaier V; Rutishauser G
    Urol Res; 1982; 10(2):75-80. PubMed ID: 6180539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid phosphatase reappraised.
    Gittes R
    N Engl J Med; 1977 Dec; 297(25):1398-9. PubMed ID: 927455
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of serum radioimmune and enzymatic prostatic acid phosphatase and radioimmune creatine kinase BB for monitoring response to therapy in metastatic prostatic carcinoma.
    Zweig MH; Ihde DC
    Cancer Res; 1985 Aug; 45(8):3945-50. PubMed ID: 3893691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic efficiency of biological markers in blood serum on prostate cancer: a comparison of four different markers and 12 different methods.
    Strømme JH; Haffner F; Johannessen NB; Talseth T; Frederichsen P; Theodorsen L
    Scand J Clin Lab Invest; 1986 Sep; 46(5):443-50. PubMed ID: 2428093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Purification and enzyme immunoassay of tumor markers for prostate cancer: prostatic acid phosphatase, prostate-specific antigen and creatine kinase BB].
    Morishita N; Minami Y; Ogawa S; Saito Y
    Nihon Hinyokika Gakkai Zasshi; 1984 Mar; 75(3):404-13. PubMed ID: 6206268
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase.
    Foti AG; Cooper JF; Herschman H; Malvaez RR
    N Engl J Med; 1977 Dec; 297(25):1357-61. PubMed ID: 73133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of value of radioimmunoassay for prostatic acid phosphatase as a screening test for prostatic cancer in patients with obstructive prostatic hyperplasia.
    Fleischmann J; Catalona WJ; Fair WR; Heston WD; Menon M
    J Urol; 1983 Feb; 129(2):312-4. PubMed ID: 6187945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The appropriate uses of prostatic acid phosphatase determination in the diagnosis of adenocarcinoma of the prostate.
    Griffiths J
    Ann N Y Acad Sci; 1982; 390():100-3. PubMed ID: 6953922
    [No Abstract]   [Full Text] [Related]  

  • 19. Acid phosphatase measurement in the clinical laboratory.
    Bowers GN
    Ann N Y Acad Sci; 1982; 390():89-99. PubMed ID: 6953926
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of radioimmunoassay of serum creatine kinase BB (CK-BB) as a tumor marker: studies in patients with various cancers and a comparison of CK-BB concentrations to prostate acid phosphatase concentrations.
    Zweig MH; Van Steirteghem AC
    J Natl Cancer Inst; 1981 May; 66(5):659-62. PubMed ID: 6939925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.